Relmada Therapeutics shares owned by Pegasus Asset Management
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Pegasus Asset Management
from 13F filings
Historical chart of Pegasus Asset Management investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Pegasus Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Pegasus Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $125k | 27k | 4.65 |
| 2023-12-31 | $112k | 27k | 4.14 |
| 2023-09-30 | $81k | 27k | 3.00 |
| 2023-06-30 | $66k | 27k | 2.46 |
| 2023-03-31 | $61k | 27k | 2.26 |
| 2022-12-31 | $94k | 27k | 3.49 |
| 2022-09-30 | $998k | 27k | 37.02 |
| 2022-06-30 | $512k | 27k | 18.99 |
| 2022-03-31 | $728k | 27k | 27.01 |
| 2021-12-31 | $607k | 27k | 22.52 |
| 2021-09-30 | $707k | 27k | 26.23 |
| 2021-06-30 | $863k | 27k | 32.01 |
| 2021-03-31 | $949k | 27k | 35.20 |
| 2020-12-31 | $865k | 27k | 32.09 |
| 2020-09-30 | $1.0M | 27k | 37.61 |
| 2020-06-30 | $1.2M | 27k | 44.74 |